It seems like a little panic selling due to today's news of pfizer set to file covid antivaral pill before thanksgiving. The panic is premature. GC has all along been saying that there is more demand than supply and Tollovir will play a big impact. This could present a good buying opportunity since early phase 2 trial readout should come out in a few weeks.
(0)
(1)
Amarantus Bioscience Holdings (AMBS) Stock Research Links